par Facciorusso, Antonio;Arvanitakis, Marianna
;Crinò, Stefano Francesco;Fabbri, Carlo;Fornelli, Adele;Leeds, John;Archibugi, Livia;Carrara, Silvia;Dhar, Jahnvi;Gkolfakis, Paraskevas;Haugk, Beate;Garcia, Julio Iglesias;Napoleon, Bertrand;Papanikolaou, Ioannis I.S.;Seicean, Andrada;Stassen, Pauline M C;Vilmann, Peter;Meloth, Thamban;Fuccio, Lorenzo
Référence Endoscopy, 57, 4, page (390-418)
Publication Publié, 2025-04-01
;Crinò, Stefano Francesco;Fabbri, Carlo;Fornelli, Adele;Leeds, John;Archibugi, Livia;Carrara, Silvia;Dhar, Jahnvi;Gkolfakis, Paraskevas;Haugk, Beate;Garcia, Julio Iglesias;Napoleon, Bertrand;Papanikolaou, Ioannis I.S.;Seicean, Andrada;Stassen, Pauline M C;Vilmann, Peter;Meloth, Thamban;Fuccio, LorenzoRéférence Endoscopy, 57, 4, page (390-418)
Publication Publié, 2025-04-01
Article révisé par les pairs
| Résumé : | This Technical and Technology Review from the European Society of Gastrointestinal Endoscopy (ESGE) represents an update of the previous document on the technical aspects of endoscopic ultrasound (EUS)-guided sampling in gastroenterology, including the available types of needle, technical aspects of tissue sampling, new devices, and specimen handling and processing. Among the most important new recommendations are:ESGE recommends end-cutting fine-needle biopsy (FNB) needles over reverse-bevel FNB or fine-needle aspiration (FNA) needles for tissue sampling of solid pancreatic lesions; FNA may still have a role when rapid on-site evaluation (ROSE) is available.ESGE recommends EUS-FNB or mucosal incision-assisted biopsy (MIAB) equally for tissue sampling of subepithelial lesions ≥20 mm in size. MIAB could represent the first choice for smaller lesions (<20 mm) if proper expertise is available.ESGE does not recommend the use of antibiotic prophylaxis before EUS-guided tissue sampling of solid masses and EUS-FNA of pancreatic cystic lesions. |



